Quick Answer
CANNAPHARMARX, INC. reported Cash and Equivalents of $0.00 for fiscal year 2017.
CANNAPHARMARX, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2017 | $0.00 | — |
| 2016 | $0.00 | -100.0% |
| 2015 | $2.6K | -99.8% |
| 2014 | $1.61M | — |
| 2013 | $0.00 | -100.0% |
| 2012 | $25.00 | +0.0% |
| 2011 | $25.00 | -75.0% |
| 2010 | $100.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2018 | $682.1K | — | +2970.3% |
| June 30, 2018 | $22.2K | — | — |
| March 31, 2018 | $0.00 | — | — |
| December 31, 2017 | $0.00 | — | — |
| September 30, 2017 | $0.00 | — | — |
| June 30, 2017 | $0.00 | — | — |
| March 31, 2017 | $0.00 | -100.0% | — |
| December 31, 2016 | $0.00 | -100.0% | — |
- Over the 2010–2017 period, CANNAPHARMARX, INC.’s cash and equivalents has declined by 100.0% (from $100.00 to $0.00).
- The most recent figure is from CANNAPHARMARX, INC.’s fiscal year 2017 report (Form 10-K), filed with the SEC on September 14, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: